Organisation paid for research Program year 2025 Source: CMS Open Payments

HealthPartners

Neither a doctor nor a teaching hospital

Research payments

$628,848

135 payments

Through program year 2025, HealthPartners is reported as receiving $628,848 in research payments, across 135 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$15,044	11
2024	Research	$378,437	32
2023	Research	$9,224	11
2022	Research	$146,676	38
2021	Research	$44,983	32
2020	Research	$5,573	4
2019	Research	$28,910	7

Breakdown

Who paid Research payments · program years 2019–2025

CSL Behring $467,030 109 payments
Ucb SA $84,438 1 payment
Medtronic, Inc. $35,915 15 payments
Medtronic Vascular, Inc. $28,910 7 payments
Celgene Corporation $8,300 2 payments
Medtronic USA, Inc. $4,254 1 payment

Studies the money was for Research payments · program years 2019–2025

A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Large Simple Trial Evaluating the Use of BE1116 (4-Factor Prothrombin Complex Concentrate [Kcentra / Beriplex]) to Improve Survival in Patients With Traumatic Injury and Acute Major Bleeding $360,655 35 payments
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome $106,375 74 payments
A Patient- and Investigator-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Bepranemab (Ucb0107) in Study Participants With Prodromal to Mild Alzheimers Disease (Ad), Followed By An Open-Label Extensio $84,438 1 payment
Investigator Sponsored Research $28,358 4 payments
Stroke AF $28,224 15 payments
Attain Stability Quad $12,497 4 payments
Celgene Connect Myeloid Disease Registry $8,300 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.